SGYP - Synergy Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $2.52. This is a potential upside of $2.52 (0%) from yesterday's end of day stock price of $0.

Synergy Pharmaceuticals's activity chart (see below) currently has 14 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 15.25 days.

Most recent stock forecast was given by TIMOTHY CHIANG from CAPITAL ONE on 26-Oct-2018. First documented stock forecast 22-May-2015.

Best performing analysts who are covering SGYP - Synergy Pharmaceuticals:

Derek Archila Liav Abraham John Newman Timothy Chiang

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7

5 years 5 months 23 days ago

0/11 (0%)

$4.97 (244.83%)

2

$1.97 (6566.67%)

13

5 years 5 months 24 days ago

0/3 (0%)

$0.6 (42.86%)

Hold

6

6 years 3 months 13 days ago

0/4 (0%)

$4.72 (131.60%)

Sell

2.5

$2.47 (8233.33%)

6 years 7 months 5 days ago

1/2 (50%)

$-0.21 (-7.75%)

61

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SGYP (Synergy Pharmaceuticals) average time for price targets to be met?

On average it took 15.25 days on average for the stock forecasts to be realized with a an average price target met ratio 12.5

Which analyst has the current highest performing score on SGYP (Synergy Pharmaceuticals) with a proven track record?

DEREK ARCHILA

Which analyst has the current lower performing score on SGYP (Synergy Pharmaceuticals) with a proven track record?

TIMOTHY CHIANG

Which analyst has the most public recommendations on SGYP (Synergy Pharmaceuticals)?

Derek Archila works at WELLS FARGO and has 3 price targets and 2 ratings on SGYP

Which analyst is the currently most bullish on SGYP (Synergy Pharmaceuticals)?

Liav Abraham with highest potential upside - $2.47

Which analyst is the currently most reserved on SGYP (Synergy Pharmaceuticals)?

Derek Archila with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?